NCT01167764

Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis

Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis: Multicenter, Prospective, Randomized, Double-blind Phase 3 Trial

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 25 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Hemoptysis is one of the serious complication of many pulmonary diseases. Upto now, there is no proven medical treatment in recurrence of hemoptysis. The investigators will conduct a randomized, placebo controlled trial of tranexamic acid, which can reduce the recurrence of hemoptysis.

Conditions

• Hemoptysis

Interventions

Type	Name	Description
DRUG	tranexamic acid, placebo	tranexamic acid 250mg tid for 1 months vs. placebo for 1 months

Timeline

• Start date: 2011-07-01
• Primary completion: 2013-07-01
• Completion: 2013-12-01
• First posted: 2010-07-22
• Last updated: 2014-01-07

Locations

3 sites across 1 country: South Korea